During the past decade, MHAT Plovdiv AD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MHAT Plovdiv AD" #1 sponsor was "Pfizer" with 3 trials, followed by "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT Plovdiv AD" #1 collaborator was "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "MHAT Plovdiv AD" are "Arthritis, Rheumatoid" (3 trials), "Rheumatoid Arthritis" (3 trials), "Atrial Fibrillation" (1 trials), "Chronic Kidney Failure" (1 trials) and "Moderate to Severe Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "MHAT Plovdiv AD" in a lesser frequency.

Most popular intervention types in "MHAT Plovdiv AD" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "peficitinib" (2 trials), "Adalimumab" (1 trials), "BI 695500" (1 trials) and "EU-Humira" (1 trials). Other intervention names were less common.

The vast majority of trials in "MHAT Plovdiv AD" are 10 trials for "All" genders.

Currently, there are NaN active trials in "MHAT Plovdiv AD". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in MHAT Plovdiv AD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT Plovdiv AD, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".